stoxline Quote Chart Rank Option Currency Glossary
  
Intelligent Bio Solutions Inc. (INBS)
4.26  -0.05 (-1.16%)    02-23 16:00
Open: 4.27
High: 4.3
Volume: 104,738
  
Pre. Close: 4.31
Low: 4.124
Market Cap: 9(M)
Technical analysis
2024-02-23 4:37:28 PM
Short term     
Mid term     
Targets 6-month :  9.46 1-year :  13.66
Resists First :  8.1 Second :  11.69
Pivot price 4.51
Supports First :  2.27 Second :  1.89
MAs MA(5) :  4.25 MA(20) :  4.05
MA(100) :  3.9 MA(250) :  20.44
MACD MACD :  0.2 Signal :  0.2
%K %D K(14,3) :  19.6 D(3) :  20
RSI RSI(14): 50.7
52-week High :  78.36 Low :  2.27
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ INBS ] has closed above bottom band by 44.4%. Bollinger Bands are 7.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.31 - 4.34 4.34 - 4.36
Low: 4.05 - 4.08 4.08 - 4.11
Close: 4.21 - 4.26 4.26 - 4.3
Company Description

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Headline News

Sat, 24 Feb 2024
Intelligent Bio Solutions: A Stock with Sky-High Potential Amidst Institutional Interest Surge - BNN Breaking

Sat, 24 Feb 2024
Intelligent Bio Solutions (INBS) Price Target Increased by 1100.00% to 113.83 - MSN

Mon, 12 Feb 2024
Why Is Intelligent Bio Solutions (INBS) Stock Down 24% Today? - InvestorPlace

Fri, 09 Feb 2024
Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q2 Revenue $764063 - Marketscreener.com

Fri, 09 Feb 2024
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights - GlobeNewswire

Tue, 06 Feb 2024
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Stock Skyrockets 146.89% - Discover the Driving Forces - Marketscreener.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 2 (M)
Shares Float 2 (M)
Held by Insiders 2.1 (%)
Held by Institutions 3.2 (%)
Shares Short 73 (K)
Shares Short P.Month 26 (K)
Stock Financials
EPS 64.68
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.22
Profit Margin 0 %
Operating Margin -260.7 %
Return on Assets (ttm) -44.7 %
Return on Equity (ttm) -200.3 %
Qtrly Rev. Growth 114.1 %
Gross Profit (p.s.) 0
Sales Per Share 1.14
EBITDA (p.s.) -4.03
Qtrly Earnings Growth 0 %
Operating Cash Flow -7 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio 0.06
PEG Ratio 0
Price to Book value 1.91
Price to Sales 3.72
Price to Cash Flow -1.26
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android